Cost-Effectiveness and Budget Impact Analysis of Apatinib for Advanced Metastatic Gastric Cancer from the Perspective of Health Insurance System

Figure 5

Estimated budget impact during fiscal years 2016 to 2020 with the provision of apatinib per one million population.